The American Academy of Allergy, Asthma & Immunology announced David A. Khan as its next executive vice president on October 28, with his term beginning in January 2027.
Khan will briefly overlap with retiring executive vice president Thomas Fleisher until the conclusion of the academy’s 2027 annual meeting, according to the organization’s announcement.
Khan previously served as academy president in 2022–23. He is a program director and professor of medicine and pediatrics at UT Southwestern and an associate editor of The Journal of Allergy and Clinical Immunology: In Practice.
His earlier academy responsibilities included chairing sections focused on training program directors and on food allergy, anaphylaxis, dermatology and drug allergy. He also spent 16 years on the joint task force responsible for practice parameters and chaired the academy’s foundation council in 2023–24.
The academy describes its membership as more than 7,100 allergists, asthma specialists, clinical immunologists and other professionals. Wednesday’s announcement establishes a future leadership transition; it does not introduce new treatment guidance or clinical findings.
Sources AAAAI October 28 appointment announcement: https://www.prnewswire.com/news-releases/david-a-khan-md-faaaai-named-new-aaaai-executive-vice-president-302922428.html